ArticleBMJ open2026

Haemoglobin vesicles as artificial red blood cells developed for use as a transfusion alternative: an open-label, single-centre phase Ib study protocol in Japan.

Kazuya Sakai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.